Vascular Diseases: Clinical Trials

546 trials for Vascular Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

546 unknown. 546 Phase 3, 142 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 3546Unknown 546
Phase 2142Unknown 142

Follow Vascular Diseases: new trials by email Literature Review of Vascular Diseases trials Research Report on Vascular Diseases

Trials (filtered) newest first · largest first

All 546 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traumatic Injury: a Multicentre Pilot Randomized Trial
Anti-Xa Guided Dosing of Low Molecular Weight Heparin, Standard of Care Dosing - Venous Thromboembolism (VTE), Trauma Related Injuries
Phase 2 / Phase 3UnknownAlexandre Tran1502025-01-012024-10-28
Safety and Efficacy of Conestat Alfa for ACE-Induced Angioedema
Conestat Alfa - ACE Inhibitor-Induced Angioedema
Phase 3UnknownUniversity of Cincinnati242024-12-012024-11-07
Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke
Tirofiban Hydrochloride, Standard medical treatment (SMT) - Acute Stroke, Ischemic Stroke, Acute
Phase 2 / Phase 3UnknownCapital Medical University3022024-11-202024-10-29
Cannabidiol's Role in Dementia Management
Cannabidiol Oil - Dementia, Vascular, Dementia, Mixed
Phase 2 / Phase 3UnknownHospital Pengajar Universiti Putra Malaysia4862024-09-012024-07-23
Ticagrelor Versus Cilostazol in Ischemic Stroke
Ticagrelor 90 MG, Cilostazol 100 MG - Ischemic Stroke
Phase 3UnknownKafrelsheikh University9002024-08-302024-08-20
Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-D )
Emergency Stroke Unit based on 0.23-T MRI, Standard stroke unit - Ischemic Stroke, Acute
Phase 3UnknownBeijing Tiantan Hospital6002024-08-102024-10-01
ESCALATion of Medical Therapy Following Multimodality Plaque Evaluation in High-risk Chronic Coronary Syndromes
Colchicine 0.5 MG - Coronary Artery Disease
Phase 3UnknownKing's College Hospital NHS Trust502024-06-242024-06-21
Single-Arm Study Evaluating Use of the CORA Catheters for the Crossing of Coronary Chronic Total Occlusions
coraFlex Catheter, coraForce Catheter, coraCross Catheter - Coronary Occlusion
Phase 3UnknownReFlow Medical, Inc.1502024-06-012024-05-10
Phase III Study to Evaluate the Efficacy and Safety of AD-209
AD-209, AD-2091, AD-209 Placebo - Hypertension,Essential
Phase 3UnknownAddpharma Inc.2802024-05-202024-05-21
Efficacy of Using 50 ml Syringe Manual Thrombectomy Catheter in Primary PCI With Heavy Thrombus Burden
30 mL syringe manual thrombectomy catheter, 50 mL syringe manual thrombectomy catheter - STEMI - ST Elevation Myocardial Infarction, Thrombosis Cardiac
Phase 3UnknownHelwan University882024-04-012024-03-26
Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke
Ticagrelor 90 MG, Cilostazol 100 MG - Ischemic Stroke
Phase 3UnknownKafrelsheikh University5802024-03-302024-08-20
Efficacy of Phentolamine in Prevention of Contrast-Associated Acute Kidney Injury After Complex PCI
Phentolamine - CA-AKI - Contrast-Associated Acute Kidney Injury, Coronary Artery Disease
Phase 2 / Phase 3UnknownHelwan University602024-03-072024-03-18
Cerebroprotective Effect of Melatonin in Stroke
Melatonin 10 MG, Placebo - Stroke, Acute Ischemic, Strokes Thrombotic
Phase 3UnknownCoordinación de Investigación en Salud, Mexico1002024-03-012024-03-05
Evaluation of Therapeutic Efficacy of Faricimab for Clinical AMD, DME, and RVO Patients
Faricimab - Age-Related Macular Degeneration, Diabetic Macular Edema
Phase 2 / Phase 3UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine302024-03-012024-08-27
NW Roselle in Grade 1 Essential Hypertension: Phase III Clinical Trial
NW Roselle, Captopril 25Mg Tab - Essential Hypertension
Phase 3UnknownNatural Wellness Egypt2862024-03-012023-11-21
GD-11 for Injection in the Treatment of Acute Ischemic Stroke
GD-11 for injection test group, Placebo control group - Acute Ischemic Stroke
Phase 3UnknownBeijing Tiantan Hospital9802024-02-292024-03-15
Shuxuening Injection for the Prevention of CVS in Patients With aSAH(SXN-CVS)
Shuxuening injection or placebo - Subarachnoid Hemorrhage, Aneurysmal
Phase 2 / Phase 3UnknownXiaolin Chen, MD502024-01-242024-04-01
Anticoagulation Using Rivaroxaban on Top of Aspirin in Intracranial Atherosclerotic Stenosis
Rivaroxaban, Clopidogrel, Aspirin - Ischemic Stroke, Intracranial Atherosclerosis
Phase 2 / Phase 3UnknownThe First Affiliated Hospital with Nanjing Medical University11802023-12-302023-12-21
Extra Alirocumab in Addition to Statin Therapy in Asymptomatic Intracranial Atherosclerotic Stenosis (EAST-aICAS)
Alirocumab, Atorvastatin - Intracranial Atherosclerosis, Atherosclerotic Plaque
Phase 3UnknownThe First Affiliated Hospital with Nanjing Medical University802023-12-302023-12-21
A Study of the Efficacy and Safety of Monotherapy With BCD-264 and Darzalex in Subjects With Relapsed and Refractory Multiple Myeloma
BCD-264, Darzalex - Multiple Myeloma
Phase 3UnknownBiocad2522023-12-212024-03-06

Showing 20 of 546. Sign in to see all of them.

Narrower conditions

Stroke (56)  ·  Ischemic Stroke (55)  ·  Coronary Artery Disease (50)  ·  Hypertension (44)  ·  Multiple Myeloma (38)  ·  ST Elevation Myocardial Infarction (25)  ·  Myocardial Infarction (24)  ·  Atherosclerosis (17)  ·  Cardiovascular Diseases (16)  ·  Acute Coronary Syndrome (15)  ·  Diabetes Mellitus (14)  ·  Myocardial Ischemia (14)  ·  Thrombosis (14)  ·  Essential Hypertension (13)  ·  Hypertension, Pulmonary (13)

Broader conditions

Cardiovascular Diseases (530)  ·  Pathological Conditions, Signs and Symptoms (201)  ·  Pathologic Processes (155)  ·  Heart Diseases (151)  ·  Nervous System Diseases (146)  ·  Central Nervous System Diseases (138)  ·  Brain Diseases (137)  ·  Cerebrovascular Disorders (133)  ·  Myocardial Ischemia (127)  ·  Arterial Occlusive Diseases (98)  ·  Arteriosclerosis (90)  ·  Ischemia (66)  ·  Infarction (60)  ·  Necrosis (60)

Interventions

Aspirin (26)  ·  Clopidogrel (25)  ·  Dexamethasone (18)  ·  Cyclophosphamide (16)  ·  Rivaroxaban (16)  ·  Atorvastatin (13)  ·  Ticagrelor (12)  ·  Saline Solution (11)  ·  Sodium Chloride (10)  ·  Cilostazol (9)  ·  Melphalan (9)  ·  Sildenafil Citrate (8)  ·  Amlodipine (7)  ·  Lenalidomide (7)  ·  Prednisone (7)

Sponsors

Kafrelsheikh University (9)  ·  Capital Medical University (8)  ·  Assiut University (7)  ·  Beijing Tiantan Hospital (6)  ·  First Affiliated Hospital of Harbin Medical University (6)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (6)  ·  University of Sao Paulo General Hospital (6)  ·  Chang Gung Memorial Hospital (5)  ·  Hospital de Clinicas de Porto Alegre (5)  ·  University Hospital Tuebingen (5)  ·  Assistance Publique - Hôpitaux de Paris (4)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (4)  ·  National Taiwan University Hospital (4)  ·  RenJi Hospital (4)  ·  Samsung Medical Center (4)

Countries

China (95)  ·  United States (37)  ·  Italy (35)  ·  Brazil (29)  ·  Canada (29)  ·  South Korea (29)  ·  Germany (27)  ·  United Kingdom (24)  ·  Egypt (22)  ·  France (22)  ·  Netherlands (19)  ·  Spain (16)  ·  Israel (12)  ·  Belgium (11)  ·  Poland (11)

Top investigators

Gang Zhao, M.D. (3)  ·  Oh Young Bang, MD (3)  ·  Arafa Gomaa, MD (2)  ·  David Zemanek, MD (2)  ·  Gunnar Tepe, MD (2)  ·  Pong Ya-Ping, MD (2)  ·  Shuya Li (2)  ·  Weon Kim, MD, PhD (2)  ·  Adam Kirton, MD MSc FRCPC (1)  ·  Adrian Corneliu Iancu, M.D, Ph.D (1)  ·  Agnes Floel, MD (1)  ·  Ahmed AH Hassan Ali, master (1)  ·  Aili He, MD, PhD (1)  ·  Ailton Melo, PHD (1)

Results publications

PMID 18190818, PMID 31867054, PMID 42573020, PMID 2375765, PMID 17825712, PMID 35244208, PMID 35422242, PMID 38648030, PMID 10737280, PMID 10811917, PMID 10963635, PMID 11105983, PMID 11137554, PMID 11231246, PMID 11315017, PMID 11673584, PMID 11914403, PMID 12393647, PMID 12510709, PMID 12628952, PMID 12651674, PMID 12807523, PMID 1342820, PMID 14578255, PMID 15007111, PMID 15131807, PMID 15189396, PMID 15711856, PMID 15738352, PMID 15842354, PMID 15861319, PMID 16103468, PMID 16168297, PMID 16260639, PMID 16337036, PMID 16427380, PMID 16475046, PMID 16644654, PMID 16914460, PMID 16916504, PMID 17138963, PMID 17315136, PMID 17360989, PMID 17509235, PMID 17548727, PMID 17634457, PMID 17859247, PMID 18094721, PMID 18165577, PMID 18166796

NIH funding

2014 (4), 2009 (3), 2018 (3), 2005 (2), 2016 (2), 2017 (2), 2015 (1), 2019 (1), R01HD021453 (1), R01HL115041 (1), R01NR017850 (1), U01HL071988 (1), U01HL077221 (1), U01HL081656 (1)